Skip to Main Content

Oxfam America has filed a complaint with securities regulators accusing Moderna (MRNA) of providing “misleading statements” and concealing material information about its dispute with the U.S. government over Covid-19 vaccine patents.

Specifically, the advocacy group maintained the company wrongfully described a simmering patent dispute with the National Institutes of Health in its regulatory filings over the past year as theoretical when, in fact, the federal government was threatening litigation. Oxfam contended Moderna should have expressly acknowledged this risk, and that its failure to do so violated securities laws.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment